Organon & Co.
OGN
$13.65
$0.030.22%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.45% | -2.08% | -2.92% | -1.69% | -1.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.45% | -2.08% | -2.92% | -1.69% | -1.02% |
| Cost of Revenue | 5.00% | 5.92% | 5.58% | 4.41% | 3.46% |
| Gross Profit | -8.14% | -8.04% | -9.07% | -6.05% | -4.20% |
| SG&A Expenses | -2.85% | -0.86% | -1.72% | 4.17% | -2.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.24% | 1.11% | 0.35% | 2.49% | -0.30% |
| Operating Income | -12.06% | -13.06% | -13.63% | -14.39% | -3.51% |
| Income Before Tax | -26.28% | -20.09% | -47.34% | -10.23% | 1.68% |
| Income Tax Expenses | 929.41% | 473.08% | 517.54% | 138.73% | 90.14% |
| Earnings from Continuing Operations | -70.14% | -67.20% | -78.36% | -61.49% | -30.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.14% | -67.20% | -78.36% | -61.49% | -30.00% |
| EBIT | -12.06% | -13.06% | -13.63% | -14.39% | -3.51% |
| EBITDA | -7.73% | -6.89% | -6.76% | -7.92% | 1.01% |
| EPS Basic | -70.52% | -67.52% | -78.50% | -61.89% | -30.57% |
| Normalized Basic EPS | -14.92% | -10.31% | -13.84% | -17.23% | 0.68% |
| EPS Diluted | -71.18% | -67.62% | -78.63% | -62.10% | -31.03% |
| Normalized Diluted EPS | -15.27% | -9.84% | -13.49% | -17.09% | 0.58% |
| Average Basic Shares Outstanding | 0.98% | 0.98% | 0.95% | 0.91% | 0.86% |
| Average Diluted Shares Outstanding | 1.29% | 0.45% | 0.52% | 0.81% | 1.06% |
| Dividend Per Share | -90.70% | -92.86% | -69.64% | -46.43% | -23.21% |
| Payout Ratio | -0.74% | -0.77% | 0.37% | 0.39% | 0.11% |